Last year, Elon Musk's Neuralink became the first to implant a brain-computer interface into a human patient. Noland Arbaugh, who was paralyzed in an accident in 2016, received "the Link" implant ...

CERo Therapeutics Holdings, Inc. has announced the initial dosing of the first patient in its Phase 1 clinical trial of CER-1236, a novel autologous CAR-T therapeutic targeting TIM 4L for acute ...

The study, which is focused on Diabetic Nephropathy and other forms of Stage 3 Chronic Kidney Disease (CKD), is being conducted as a double-blinded, randomized, controlled trial in accordance with ...

KJ had become the world’s first patient to be treated with a personalized CRISPR therapy that made a correction directly to the genome. Before hopping on a press briefing with reporters, Nicole ...

Historically, patient satisfaction has been measured through traditional methods like paper surveys, in-person interviews and feedback forms. While these approaches offer a direct line of ...

Marley Mansour, 11, stands on her bed at her home in Rowlett on Tuesday, April 29, 2025. Mansour is set to make medical history as the first person in the world to receive treatment for NARS1, a ...

said Yanshan Huang, Ph.D., founder and Chief Executive Officer of Doer Bio. "We're pleased to announce the dosing of first patient in our Phase 2 study of DR10624 for the treatment of MASLD/MASH.

The first patient has been dosed in a phase 1/2 clinical trial evaluating KSQ-004EX in solid tumors including melanoma, non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC ...

ANNAPOLIS, Md., April 8, 2025 /PRNewswire/ -- Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics ®, announced today that the first patient has been ...

"We are pleased to have enrolled the first patient in our REDUCE 1 study, our second confirmatory Phase 3 trial evaluating AR882's potential as a best-in-class treatment," said Litain Yeh, Ph.D ...